328 related articles for article (PubMed ID: 34568453)
1. Histone Methylation Related Therapeutic Challenge in Cardiovascular Diseases.
Yang Y; Luan Y; Yuan RX; Luan Y
Front Cardiovasc Med; 2021; 8():710053. PubMed ID: 34568453
[TBL] [Abstract][Full Text] [Related]
2. Treatment of cardiovascular pathology with epigenetically active agents: Focus on natural and synthetic inhibitors of DNA methylation and histone deacetylation.
Chistiakov DA; Orekhov AN; Bobryshev YV
Int J Cardiol; 2017 Jan; 227():66-82. PubMed ID: 27852009
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic Regulation of Macrophage Polarization in Cardiovascular Diseases.
Komal S; Han SN; Cui LG; Zhai MM; Zhou YJ; Wang P; Shakeel M; Zhang LR
Pharmaceuticals (Basel); 2023 Jan; 16(2):. PubMed ID: 37259293
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic gene regulation by plant Jumonji group of histone demethylase.
Chen X; Hu Y; Zhou DX
Biochim Biophys Acta; 2011 Aug; 1809(8):421-6. PubMed ID: 21419882
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic targets and drug discovery Part 2: Histone demethylation and DNA methylation.
Liu K; Liu Y; Lau JL; Min J
Pharmacol Ther; 2015 Jul; 151():121-40. PubMed ID: 25857453
[TBL] [Abstract][Full Text] [Related]
6. Potential regulatory role of epigenetic RNA methylation in cardiovascular diseases.
Komal S; Zhang LR; Han SN
Biomed Pharmacother; 2021 May; 137():111376. PubMed ID: 33588266
[TBL] [Abstract][Full Text] [Related]
7. Involvement of Epigenetic Control and Non-coding RNAs in Cardiovascular System.
Sharma S; Mishra A; Ashraf MZ
Adv Exp Med Biol; 2020; 1229():121-132. PubMed ID: 32285408
[TBL] [Abstract][Full Text] [Related]
8. Evolving insights on histone methylome regulation in human acute myeloid leukemia pathogenesis and targeted therapy.
Boila LD; Sengupta A
Exp Hematol; 2020 Dec; 92():19-31. PubMed ID: 32950598
[TBL] [Abstract][Full Text] [Related]
9. Epigenetics and Beyond: Targeting Histone Methylation to Treat Type 2 Diabetes Mellitus.
Yang Y; Luan Y; Feng Q; Chen X; Qin B; Ren KD; Luan Y
Front Pharmacol; 2021; 12():807413. PubMed ID: 35087408
[TBL] [Abstract][Full Text] [Related]
10. Advances in Epigenetic Cancer Therapeutics.
Hillyar C; Rallis KS; Varghese J
Cureus; 2020 Nov; 12(11):e11725. PubMed ID: 33391954
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic-related therapeutic challenges in cardiovascular disease.
Schiano C; Vietri MT; Grimaldi V; Picascia A; De Pascale MR; Napoli C
Trends Pharmacol Sci; 2015 Apr; 36(4):226-35. PubMed ID: 25758254
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic potential of ALKB homologs for cardiovascular disease.
Xiao MZ; Liu JM; Xian CL; Chen KY; Liu ZQ; Cheng YY
Biomed Pharmacother; 2020 Nov; 131():110645. PubMed ID: 32942149
[TBL] [Abstract][Full Text] [Related]
13. Regulation of histone arginine methylation/demethylation by methylase and demethylase (Review).
Zhang J; Jing L; Li M; He L; Guo Z
Mol Med Rep; 2019 May; 19(5):3963-3971. PubMed ID: 30942418
[TBL] [Abstract][Full Text] [Related]
14. Writing, erasing and reading histone lysine methylations.
Hyun K; Jeon J; Park K; Kim J
Exp Mol Med; 2017 Apr; 49(4):e324. PubMed ID: 28450737
[TBL] [Abstract][Full Text] [Related]
15. Emergent expansion of clinical epigenetics in patients with cardiovascular diseases.
Napoli C; Coscioni E; de Nigris F; Donatelli F
Curr Opin Cardiol; 2021 May; 36(3):295-300. PubMed ID: 33605616
[TBL] [Abstract][Full Text] [Related]
16. Insights into the epigenetic mechanisms involving histone lysine methylation and demethylation in ischemia induced damage and repair has therapeutic implication.
Chakravarty S; Jhelum P; Bhat UA; Rajan WD; Maitra S; Pathak SS; Patel AB; Kumar A
Biochim Biophys Acta Mol Basis Dis; 2017 Jan; 1863(1):152-164. PubMed ID: 27664837
[TBL] [Abstract][Full Text] [Related]
17. Histone Methylation Regulation in Neurodegenerative Disorders.
Basavarajappa BS; Subbanna S
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925016
[TBL] [Abstract][Full Text] [Related]
18. The molecular landscape of histone lysine methyltransferases and demethylases in non-small cell lung cancer.
Li J; Tao X; Shen J; Liu L; Zhao Q; Ma Y; Tao Z; Zhang Y; Ding B; Xiao Z
Int J Med Sci; 2019; 16(7):922-930. PubMed ID: 31341405
[No Abstract] [Full Text] [Related]
19. Targeting histone methyltransferases and demethylases in clinical trials for cancer therapy.
Morera L; Lübbert M; Jung M
Clin Epigenetics; 2016; 8():57. PubMed ID: 27222667
[TBL] [Abstract][Full Text] [Related]
20. Targeting histone methylation for colorectal cancer.
Huang T; Lin C; Zhong LL; Zhao L; Zhang G; Lu A; Wu J; Bian Z
Therap Adv Gastroenterol; 2017 Jan; 10(1):114-131. PubMed ID: 28286564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
